Guerrero, P.; Albarrán, V.; San Román, M.; González-Merino, C.; García de Quevedo, C.; Moreno, J.; Calvo, J.C.; González, G.; Orejana, I.; Chamorro, J.;
et al. BRAF Inhibitors in Metastatic Colorectal Cancer and Mechanisms of Resistance: A Review of the Literature. Cancers 2023, 15, 5243.
https://doi.org/10.3390/cancers15215243
AMA Style
Guerrero P, Albarrán V, San Román M, González-Merino C, García de Quevedo C, Moreno J, Calvo JC, González G, Orejana I, Chamorro J,
et al. BRAF Inhibitors in Metastatic Colorectal Cancer and Mechanisms of Resistance: A Review of the Literature. Cancers. 2023; 15(21):5243.
https://doi.org/10.3390/cancers15215243
Chicago/Turabian Style
Guerrero, Patricia, Víctor Albarrán, María San Román, Carlos González-Merino, Coral García de Quevedo, Jaime Moreno, Juan Carlos Calvo, Guillermo González, Inmaculada Orejana, Jesús Chamorro,
and et al. 2023. "BRAF Inhibitors in Metastatic Colorectal Cancer and Mechanisms of Resistance: A Review of the Literature" Cancers 15, no. 21: 5243.
https://doi.org/10.3390/cancers15215243
APA Style
Guerrero, P., Albarrán, V., San Román, M., González-Merino, C., García de Quevedo, C., Moreno, J., Calvo, J. C., González, G., Orejana, I., Chamorro, J., Martínez-Delfrade, Í., Morón, B., de Frutos, B., & Ferreiro, M. R.
(2023). BRAF Inhibitors in Metastatic Colorectal Cancer and Mechanisms of Resistance: A Review of the Literature. Cancers, 15(21), 5243.
https://doi.org/10.3390/cancers15215243